ABSTRACT-The effects of various nootropic candidates on mescaline-induced head-twitches were stud ied in mice. The number of head-twitches induced by mescaline (100 mg/kg, s.c.) was significantly re duced by idebenone (32 and 100 mg/kg, i.p.), minaprine (0.32-10 mg/kg, p.o.) and nebracetam (100 mg/kg, p.o.). Cholinesterase inhibitors such as tetrahydroaminoacridine (1 and 10 mg/kg, p.o.), NIK 247 (10 and 18 mg/kg, p.o.) and physostigmine (0.32 mg/kg, i.p.) also suppressed the head-twitch re sponse to mescaline. These results suggest that the direct or indirect cholinergic-activating effects of these drugs may be involved in inhibiting mescaline-induced head-twitches.
Hallucinogenic drugs and the serotonin (5-HT) pre cursor 5-hydroxytryptophan cause a characteristic head twitch behavior in mice and rats, which is associated with hallucinogenic activity in humans (1 -3) . It has been reported that the 5-HT agonist mescaline-induced head-twitches are inhibited by various 5-HT antagonists including the selective 5-HT2 receptor antagonists ketanserin and pirenperone and that antagonism of mescaline correlates with inhibition of [3H]spiperone binding to the rat prefrontal cortex in vitro (4) . These findings indicate that the head-twitches induced by mes caline are mediated by central 5-HT2 receptors. Recent ly, 5-HT was found to inhibit the release of acetylcho line by activating 5-HT2 receptors in the rat brain (5) . Furthermore, the muscarinic receptor antagonist atro pine can produce head-twitches in mice (1) . Thus, it is likely that suppression of the cholinergic function may contribute to the appearance of mescaline-induced head-twitches. In this study, we investigated the effects of various nootropic candidates with cholinergic activating actions on the head-twitches induced in mice by mescaline.
The animals used were male ddY strain mice (20-35 g) obtained from Nippon SLC. The mice were housed in a room maintained at a temperature of 23 ± 2°C with a 12-hr light-dark cycle (light period: 07:00 19:00). Food and water were available ad libitum throughout the experiment. The number of head-twitches was counted during the 20 min period, starting 20 min after s.c.-injection of mescaline at 100 mg/kg. For observation, the mice were placed in a transparent glass cylinder (20 cm in height and 13 cm in inner diameter) immediately after the mescaline injection. The drugs used were idebenone (Takeda Chemical Industries Ltd.), minaprine (Sanofi; Taisho Phar maceutical Co., Ltd.), nebracetam (WEB 1881 FU, Nippon Boehringer Ingelheim), aniracetam (Nippon Roche), THA (tetrahydroaminoacridine hydrochloride, Aldrich), NIK-247 (Nikken Chemical Co., Ltd.), phy sostigmine salicylate (Sigma Chemical Co.) and mesca line hydrochloride. Idebenone and aniracetam were sus pended in 5% gum arabic and 1% carboxymethylcellu lose solution, respectively. Other drugs were dissolved in distilled water. Drugs were given p.o., except as noted, in a volume of 0.1 ml per 10 g body weight. Idebenone, minaprine, nebracetam and aniracetam were given 20 min before the mescaline injection. The other drugs were given 10 min before mescaline. The statistical significance of the effects of the drugs on the number of head-twitches was determined by a one-way analysis of variance (ANOVA) followed by Dunnett's test.
Idebenone (10-100 mg/kg, i.p.) produced a dose-de pendent reduction in the number of head-twitches in duced by s.c. injection of 100 mg/kg mescaline [F(3, 36) = 14.6, P < 0.01], an effect that reached signifi cance for the 32 and 100 mg/kg doses ( Table 1) In this study, the head-twitches induced by mescaline were inhibited by cholinesterase inhibitors such as THA, NIK-247 and physostigmine (6, 7) . Minaprine and nebracetam have been shown to act as agonists at M,-muscarinic receptors in the rat brain (8, 9) and to reverse scopolamine-induced memory deficits in rats (10, 11) . Results of behavioral tests indicate that idebenone also has some cholinergic-activating action (12) . Thus, the direct and indirect cholinergic-activating actions of the nootropic candidates examined in this study may play a role in inhibiting mescaline-induced head-twitches. On the other hand, cortical cholinergic activity decreases in senile dementia, and the reduction in choline acetyltransferase in the parietal and temporal cortex is more severe in patients with hallucinations than in those without them (13) . This finding indicates that lowering of cerebral cholinergic activity is related to the incidence of hallucinations in patients with senile dementia. The present results showing that mescaline induced head-twitches were inhibited by various nootro pic candidates with cholinergic-activating actions sug gest the efficacy of these drugs for the halluci nations/delusions that occur in patients with senile de mentia. 
